263 related articles for article (PubMed ID: 16788159)
1. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
Jutooru I; Chadalapaka G; Lei P; Safe S
J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
[TBL] [Abstract][Full Text] [Related]
3. Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
Abdelrahim M; Baker CH; Abbruzzese JL; Sheikh-Hamad D; Liu S; Cho SD; Yoon K; Safe S
Cancer Res; 2007 Apr; 67(7):3286-94. PubMed ID: 17409437
[TBL] [Abstract][Full Text] [Related]
4. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells.
Abdelrahim M; Smith R; Burghardt R; Safe S
Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
[TBL] [Abstract][Full Text] [Related]
6. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.
Colon J; Basha MR; Madero-Visbal R; Konduri S; Baker CH; Herrera LJ; Safe S; Sheikh-Hamad D; Abudayyeh A; Alvarado B; Abdelrahim M
Invest New Drugs; 2011 Feb; 29(1):41-51. PubMed ID: 19851711
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
Wei D; Wang L; He Y; Xiong HQ; Abbruzzese JL; Xie K
Cancer Res; 2004 Mar; 64(6):2030-8. PubMed ID: 15026340
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
Abdelrahim M; Safe S
Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
[TBL] [Abstract][Full Text] [Related]
10. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
Papineni S; Chintharlapalli S; Abdelrahim M; Lee SO; Burghardt R; Abudayyeh A; Baker C; Herrera L; Safe S
Carcinogenesis; 2009 Jul; 30(7):1193-201. PubMed ID: 19406933
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
[TBL] [Abstract][Full Text] [Related]
12. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
Pathi S; Li X; Safe S
Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
[TBL] [Abstract][Full Text] [Related]
13. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
[TBL] [Abstract][Full Text] [Related]
14. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
Higgins KJ; Abdelrahim M; Liu S; Yoon K; Safe S
Biochem Biophys Res Commun; 2006 Jun; 345(1):292-301. PubMed ID: 16678129
[TBL] [Abstract][Full Text] [Related]
16. Specificity Proteins (Sp) and Cancer.
Safe S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982239
[TBL] [Abstract][Full Text] [Related]
17. Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy.
Sankpal UT; Maliakal P; Bose D; Kayaleh O; Buchholz D; Basha R
Curr Med Chem; 2012; 19(22):3779-86. PubMed ID: 22725697
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
Jia Z; Gao Y; Wang L; Li Q; Zhang J; Le X; Wei D; Yao JC; Chang DZ; Huang S; Xie K
Cancer Res; 2010 Feb; 70(3):1111-9. PubMed ID: 20086170
[TBL] [Abstract][Full Text] [Related]
20. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
